Oxford-AstraZeneca vaccine
-
Oxford-AstraZeneca vaccine approved for use in UK
The Government has ordered 100 million doses – enough to vaccinate 50 million people – and the first doses are due to be given on 04 January amid rising coronavirus cases.
-
Oxford Vaccine up to 90% effective and to be sold at cost to developing nations
The University of Oxford and AstraZeneca vaccine ChAdOx1 nCoV-2019 is up to 90% effective at preventing COVID-19 and will be sold at cost to developing nations in perpetuity.
-
Oxford Uni’s vaccine research and development boosted by £3.3m gift from Wafic Saïd
The University of Oxford has secured a critical professorship in vaccinology for the future following a gift of £3.33 million from the Saïd family.